2[1]Moorrh J F, Chan M K, El-Nahas M, et al. Lipid nephrotoxicity in chronic progressive glomeruler and tubulointerstitial disease. Lancet, 1982, 2: 1309-1311.
3[2]Schmitz P G, O'Donnell M P. Diet-induced hypercholesterolemin elevate glomercular capillary pressure (abstract).Kidney Int, 1989, 35: 4734-4740.
4[3]Safer M E,Blacher J,Pnnier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension,2002,39:735-744.
5[4]Ruilope L M, Lahear V, Rodicio J L, et al. Are renal hemolynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension, 1994, 23:3-9.
6[5]Ruilope L M, Alcazar J M, Rodicio J L. Renal consequences of arterial hypertension. J Hypertens, 1992, 10 (Supple 7):85-90.
7[6]Tierney W M, Harris L E,Copley J B, et al. Effect of hypertension and typer 2 diabetes on renal function in an urban population, Am J Hypertens, 1990, 3:69-75.
8Saruta T, Ogihara T, Matsuoka H, et al. Antihypertensive efficacy and safety of fixed - dose combination with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension [ J] . Hypertens Res, 2007, 30 (8): 729-39.
9Ramon C, Hermida, Carlos Calvo, et al. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects [ J ] . Hypertension, 2005, 46 (9) : 960 - 968.
10Labrecque G, Beauchamp D. Rhythms and pharmacokinetics. In: Redfern P, ed. Chronotherapeutics [ M ] . London Pharmaceutical Press, 2003 : 75 - 110.
